Ideation: 9VK4R2 Complementary engineered liposomes (CEL) as cancer-targeted therapeutics. 1-3: Boston Childrens Hospital : Guo, P; Moses, M; Yang, J. ; 4-5 CCNY: Auguste, Debra; Liu, Daxing.

For more information or to license this innovation:

IDEA #9VK4R2 Complementary engineered liposomes (CEL) as cancer-targeted therapeutics. 1-3: Boston Childrens Hospital : Guo, P; Moses, M; Yang, J. ; 4-5 CCNY: Auguste, Debra; Liu, Daxing.